DiscoverPharma SessionsCombining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals
Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals

Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals

Update: 2025-02-28
Share

Description

In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health. 

They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks.

  •  Introduction and startling data on prescription abuse
  •  Welcome and guest introduction
  •  Paul Howe's breakfast routine
  •  Career background and current role
  •  Challenges with opioid prescriptions
  •  Risk stratification and mitigation for patients
  •  Pharmaceutical manufacturing quotas and regulation
  •  Future outlook for pain management and public health


Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals

Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals

Jonathan Kaskey